Wittenberg Investment Management, Inc. Mei Pharma, Inc. Transaction History

Wittenberg Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Feb 09, 2024	BUY	$0.21 - $0.35 $15,120 - $25,200	72,000 New	72,000 $16,000
Q1 2023 May 15, 2023	BUY	$0.21 - $0.35 $15,120 - $25,200	72,000 New	72,000 $16,000
Q2 2018 Jul 31, 2018	SELL	$1.89 - $4.95 $129,274 - $338,575	-68,399 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$2.06 - $2.38 $37,080 - $42,840	18,000 Added 35.71%	68,399 $142,000
Q3 2017 Nov 13, 2017	BUY	$2.44 - $2.91 $122,973 - $146,661	50,399	50,399 $135,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Wittenberg Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Wittenberg Investment Management, Inc. with notifications on news.